Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)

Phase Distribution

Ph not_applicable
2
40%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(1)
Terminated(1)
Other(1)

Detailed Status

Not yet recruiting1
Terminated1
Completed1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

not_yet_recruiting120%
terminated120%
completed120%
recruiting120%
unknown120%

Recent Activity

1 active trials
Showing 5 of 5
terminated

Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema

NCT04963634
not_yet_recruitingnot_applicable

Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer

NCT07042867
recruiting

The Patient Cohort of the National Center for Precision Medicine in Leukemia

NCT05326919
completed

Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors

NCT04586894
unknownnot_applicable

Diabetic/Metabolic Cardiomyopathy: Prevalence and Phenotype

NCT05181631

Clinical Trials (5)

Showing 5 of 5 trials
NCT04963634

Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema

Terminated
NCT07042867Not Applicable

Prospective Multicenter Cohort Study for the Development and Evaluation of Risk Stratification Tools for Lung Cancers and Their Postoperative Recurrences Using Multimodal Clinical, Radiological, Tissue and Longitudinal Biological Phenotyping Among People at Risk of Lung Cancer

Not Yet Recruiting
NCT05326919

The Patient Cohort of the National Center for Precision Medicine in Leukemia

Recruiting
NCT04586894

Adverse Myocardial and Vascular Side Effects of Immune Checkpoint Inhibitors

Completed
NCT05181631Not Applicable

Diabetic/Metabolic Cardiomyopathy: Prevalence and Phenotype

Unknown

All 5 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
5